市場調查報告書
商品編碼
1465952
全球透析器市場:按類型、薄膜材料、超過濾係數、配置、最終用戶 - 2024-2030 年預測Dialyzer Market by Type, Membrane Material, Ultrafiltration Coefficient, Configuration, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年全球透析器市場規模為119.8億美元,預計2024年將達126.5億美元,2030年將達176.2億美元,複合年成長率為5.66%。
透析器的世界也被稱為人工腎,它通過去除廢物和多餘的水來淨化血液。
主要市場統計 | |
---|---|
基準年[2023] | 119.8億美元 |
預測年份 [2024] | 126.5億美元 |
預測年份 [2030] | 176.2億美元 |
複合年成長率(%) | 5.66% |
全球透析器市場由製造、分銷和銷售用於腎衰竭患者透析過程的透析器全球設備的公司組成。全球慢性腎臟病(CKD)和末期腎病(ESRD)等腎臟疾病的盛行率不斷上升,推動了對透析治療的需求。提供卓越性能和患者舒適度的透析設備創新本質上正在擴大市場。新興國家醫療基礎設施的改善和醫療便利性也有助於市場擴張。然而,與透析程序和透析設備相關的高成本對醫療保健提供者和患者來說都是負擔。新透析器世界的嚴格監管和核准流程可能會阻礙市場成長和創新。此外,近期新興市場的開拓帶動了市場的擴張,透過家用可攜式透析設備、穿戴式式透析技術的進步以及生物人工透析技術,為滿足患者友好且高效的腎臟替代治療日益成長的需求創造了可能性。此外,數位技術的整合預計將有助於患者監測和提供個人化腎臟疾病治療的市場成長。
類型:由於高效率,高助焊劑透析器越來越偏好
高助焊劑透析器世界推薦給需要高效率去除毒素(例如中等分子)的患者。高助焊劑透析器的世界具有較大的孔徑和優異的滲透性,使其成為清除需求較高的血液透析機患者的首選,以及高效、高助焊劑血液透析機和過濾等治療的選擇也有很多。低助焊劑透析器非常適合需要維持性血液透析機(重點是小分子清除)的患者。低流量透析膜的特徵是孔徑小、透水性低,導致液體清除速度慢,適合心血管系統不穩定的患者。蛋白質滲漏膜,也稱為中型截留膜,是一種新型膜,旨在去除更廣泛的尿毒症毒素,同時最大限度地減少白蛋白等有用蛋白質的損失。蛋白質滲漏膜透析器適合需要保存此類蛋白質的患者,並且有可能改善患者的治療結果。
膜材料:再生纖維素膜的進展以提高生物相容性
醋酸纖維素膜透析器以其卓越的生物相容性和有效去除小分子而聞名。醋酸纖維素膜透析器已被證明能夠可靠地去除尿毒症毒素,使其成為低血流量或出現低血壓等透析相關症狀的患者的首選。與改性的纖維素膜相比,改性纖維素的再生纖維素膜具有更好的生物相容性和更低的過敏反應風險。替換纖維膜透析器的世界是一種由中空纖維形成的合成膜,可為透析提供較大的表面積。它以其高透析效率和耐用性而受到認可,並因能有效去除中、大分子而受到需要高助焊劑透析的患者的青睞。合成膜透析器使用聚碸、聚醚碸和聚丙烯腈。世界合成膜透析器具有優異的生物相容性和機械強度,有效清除各種尿毒症毒素。
超過濾係數:應選擇超過濾係數低的薄膜。
高效透析器的設計具有較高的超過濾係數 (Kuf),通常為 20mL/h/mmHg 或更高,這樣可以在給定的時間內過濾更多的液體。高效透析器對於需要短期、密集透析或需要在有限時間內去除大量液體或溶質的患者特別有利。低過濾係數透析器是透析器領域中Kuf為10mL/h/mmHg或更低的一類,用於心血管系統不穩定、需要更逐步排出液體的患者,以及因血壓升高而導致的低血壓患者。較低的超過濾率可以更逐步地去除水分,並減少透析治療期間低血壓的可能性。
組成:提高扁平式透析器在世界各地腎臟病漸進透析的使用率
平板透析器專為對中空纖維透析器體外體積敏感的患者而設計,用於需要精確超過濾控制的場合。對於血流受限、需要溫和透析的腎臟疾病患者,通常首選平板透析器。中空纖維透析器具有細小的中空合成纖維,血液流經其中,透析液在纖維外部流動。中空纖維透析器是最常用的透析器世界,其特徵是效率高、操作方便、生物相容性高。管式透析器採用螺旋管膜,血液在膜內循環,周圍被透析液包圍。管式透析器用於患有併發症或特殊醫療狀況而無法使用片狀濾膜或中空纖維類型的患者。管式透析器可以根據個別患者的需求進行客製化,但它們的效率通常低於中空纖維類型。
最終用戶:家庭透析治療設施中的各種應用,以提高舒適度
家庭透析治療部分針對的是要求並由醫療保健專業人員推薦在家中進行透析治療的患者。尋求家庭透析治療的病人需要更多的自主權、舒適度和長期成本節省。此外,透析技術的進步使家用透析設備更易於使用且更緊湊,擴大了家庭透析治療的可能性。中心透析是指在專門診所或醫院進行的治療。透析中心的透析適合因病情不穩定、家中無法提供透析環境或純粹個人喜好而需要更高級治療的患者。由於透析中心是受控環境,因此如果需要,您可以立即獲得醫療護理,醫療專業人員隨時待命,並且透析程序按照標準方案進行。
區域洞察
美國和加拿大慢性腎臟病(CKD) 和糖尿病的高盛行率意味著對腎臟護理的需求很高,這推動了這些地區對透析器的全球需求。由於技術進步和強大的醫療基礎設施,美洲地區創新透析產品的採用率很高。歐盟 (EU) 國家擁有世界上透析器採用率最高的國家,並有嚴格的醫療法規和完善的報銷制度支持。最近對歐洲各地透析診所和研究設施的投資顯示該市場的穩定成長。在中東國家,影響腎臟健康的文明病呈上升趨勢,導致醫療基礎設施投資增加。在亞太地區,政府改善醫療保健服務和本地透析產品生產的舉措近年來推動了市場的發展。亞太國家越來越注重國內創新和自力更生,新透析技術專利不斷激增,反映出進口替代的趨勢。
FPNV定位矩陣
FPNV定位矩陣對於評估全球透析器市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對全球透析器市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動以及突破性產品開發的智力見解。
1.全球透析器市場規模及預測為何?
2.在全球透析器市場的預測期間內,有哪些產品、細分市場、應用和細分市場需要考慮投資?
3.全球透析器市場的技術趨勢和法規結構是什麼?
4.全球透析器市場主要廠商的市場佔有率為何?
5.進入全球透析器市場的適當型態或策略手段是什麼?
[193 Pages Report] The Dialyzer Market size was estimated at USD 11.98 billion in 2023 and expected to reach USD 12.65 billion in 2024, at a CAGR 5.66% to reach USD 17.62 billion by 2030.
A dialyzer is also known as an artificial kidney that purifies the blood by removing waste products and excess fluids, a function that is compromised in individuals with kidney failure.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 11.98 billion |
Estimated Year [2024] | USD 12.65 billion |
Forecast Year [2030] | USD 17.62 billion |
CAGR (%) | 5.66% |
The dialyzer market comprises companies that manufacture, distribute and sell dialyzer devices used in dialysis processes for patients suffering from renal failure. The rising prevalence of kidney diseases such as chronic kidney diseases (CKD) and end-stage renal disease (ESRD) worldwide fuels the demand for dialysis treatments. Technological innovations in dialysis equipment that offer superior performance and greater patient comfort inherently expand the market. The enhanced healthcare infrastructure and accessibility in developing countries contribute to market expansion. However, high expenses associated with dialysis procedures and equipment can be prohibitive for both healthcare providers and patients. Stringent regulations and approval processes for new dialyzers can hinder market growth and innovation. Moreover, recent developments generate potential for market expansion through portable dialysis devices for home use, advancements in wearable dialyzers, and bioartificial dialysis technologies, all catering to the growing need for patient-friendly and efficient kidney replacement therapies. The integration of digital technologies is also anticipated to contribute market growth for patient monitoring and offering personalized renal disease treatments.
Type: Increasing preference for High-flux dialyzers due to high efficiency
High-flux dialyzers are recommended for patients who require high efficiency in toxin removal, such as middle molecules. High-flux dialyzers have larger pore sizes and more excellent permeability and are often preferred for hemodialysis patients with more significant clearance needs or in treatments such as high-efficiency and high-flux hemodialysis, and hemodiafiltration. Low-flux dialyzers are suitable for patients needing maintenance hemodialysis, focusing on small molecule clearance. Low-flux dialyzers are characterized by smaller pore sizes and lower permeability, which makes them well-suited for patients with cardiovascular instability as they allow for slower fluid removal. Protein-leaking membrane dialyzers, also known as medium cut-off dialyzers, are a newer class designed to remove a wider range of uremic toxins while minimizing the loss of useful proteins such as albumin. Protein-leaking membrane dialyzers are suitable for patients for whom preserving such proteins is critical, potentially improving patient outcomes.
Membrane Material: Advancements in regenerated cellulose membranes for better biocompatibility
Acetate cellulose membrane dialyzers are known for good biocompatibility and allow for the efficient removal of small molecules. Acetate cellulose membrane dialyzers are preferred for patients with low blood flow rates or those who experience dialysis-related symptoms such as hypotension due to their proven capability to provide reliable uremic toxin removal. Regenerated cellulose membranes, produced by the modification of cellulose, provide better biocompatibility compared to unmodified cellulose membranes and have a lower risk of hypersensitivity reactions. Replace fiber membrane dialyzers are synthetic membranes formed by hollow fibers, providing a large surface area for dialysis. Replace fiber membrane dialyzers are recognized for their high efficiency and durability and are preferred for patients requiring high flux dialysis due to their ability to remove middle to large-sized molecules effectively. Synthetic fiber membrane dialyzers utilize polysulfone, polyethersulfone, and polyacrylonitrile. Synthetic fiber membrane dialyzers offer superior biocompatibility and mechanical strength and effectively clear a wide range of uremic toxins.
Ultrafiltration Coefficient: Need based preference for low ultrafiltration coefficient dialyzer
High-efficiency dialyzers are designed to have a high ultrafiltration coefficient (Kuf), typically above 20 mL/h/mmHg, allowing a greater fluid volume to be filtered within a given time. High-efficiency dialyzers are particularly advantageous for patients requiring short but intensive dialysis sessions and when there is a need to remove a large volume of fluid or solutes over a limited time. Low Ultrafiltration Coefficient Dialyzer is a category of dialyzer with a Kuf below 10 mL/h/mmHg, often utilized for patients who require gentler fluid removal due to cardiovascular instability or those with a high risk for dialysis-induced hypotension. The lower ultrafiltration rate allows for more gradual removal of fluids, reducing the potential for hypotensive episodes during dialysis treatment.
Configuration: Rising utilization of Flat-type dialyzers for gentle dialysis in renal disease conditions
Flat type dialyzers are designed for patients who might be sensitive to the larger extracorporeal volume of hollow fiber dialyzers and are used in scenarios where precise control over ultrafiltration is required. Flat-type dialyzers are generally preferred when there is limited blood flow, necessitating gentle dialysis in renal disease conditions. Hollow fiber dialyzers contain tiny, hollow synthetic fibers through which blood flows, while dialysate flows around the outside of the fibers. Hollow fiber dialyzers are the most commonly used type of dialyzers, offering high efficiency and easy handling and have a high biocompatibility profile. Tube-type dialyzers utilize a coiled tubular membrane through which blood circulates internally, surrounded by the dialysate. Tube-type dialyzers are used when the patient presents complications or specific medical conditions that prevent using flat or hollow fiber types. Tube-type dialyzers may be customized to meet individual patient needs, although they are generally less efficient than the hollow fiber design.
End-User: Diverse applications in home dialysis facilities for increased comfort
The home dialysis segment caters to patients who prefer, and are recommended by healthcare professionals, to undergo dialysis treatment at home. Need-based preference for home dialysis typically arises from the patient's desire for increased autonomy, comfort, and potential cost savings over the long term. Moreover, advances in dialysis technology have made home dialysis machines more user-friendly and compact, expanding the accessibility of home treatment. In-center dialysis refers to treatments that take place in specialized clinics or hospital settings. In-center dialysis caters to patients who require a higher level of care, possibly due to unstable medical conditions, lack of a suitable home environment, or simply personal preference. The controlled environment of dialysis centers allows for immediate medical attention if required, and the presence of healthcare professionals ensures that dialysis procedures follow standard protocols.
Regional Insights
In the Americas region, the United States, and Canada, the high prevalence of chronic kidney disease (CKD) and diabetes lead to significant kidney care needs, significantly driving demand for dialyzers in the region. With technological advancements and robust healthcare infrastructure, the Americas region exhibits a strong adoption rate for innovative dialysis products. European Union (EU) countries demonstrate a high adoption rate of dialyzers, backed by stringent healthcare regulations and a well-established reimbursement system. Recent investments in dialysis clinics and research facilities across European countries indicate steady growth in the market space. The Middle East countries are witnessing a growing prevalence of lifestyle-related diseases affecting kidney health, leading to increased investments in healthcare infrastructure in the region. In the APAC region, the government's efforts to improve healthcare access and local manufacturing of dialysis products have propelled the market in recent years. The increasing focus on domestic innovation and self-reliance in the APAC countries showcases a surge in patents related to novel dialysis technologies, reflecting a trend towards import substitution.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Dialyzer Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dialyzer Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Dialyzer Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Allmed Medical Care Holdings Limited, Asahi Kasei Corporation, AWAK Technologies, B. Braun SE, Bain Medical Equipment (Guangzhou) Co., Ltd, Baxter International, Inc., Browndove Healthcare Pvt. Ltd., Cantel Medical Corporation, Dialife SA, Farmasol Medical Products Ind. and Trd. Co., Fresenius Medical Care AG & Co. KGaA, Lepu Medical Technology(Beijing)Co.,Ltd., Medica Trading LLC, Medtronic PLC, Nikkiso Co., Ltd., Nipro Corporation, Poly Medicure Ltd., Sb-Kawasumi Laboratories, Inc., Shandong Weigao Group Medical Polymer Company Limited, and Toray Industries, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Dialyzer Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dialyzer Market?
3. What are the technology trends and regulatory frameworks in the Dialyzer Market?
4. What is the market share of the leading vendors in the Dialyzer Market?
5. Which modes and strategic moves are suitable for entering the Dialyzer Market?